PETS241220P10000
- 0.00
- 0.000.00%
PetMed Express Newsroom
Morgan Stanley Sticks to Their Sell Rating for Petmed Express (PETS)
Morgan Stanley Maintains PetMed Express(PETS.US) With Sell Rating, Maintains Target Price $3.5
Morgan Stanley Reaffirms Their Sell Rating on Petmed Express (PETS)
PetMed Express Analyst Ratings
Petmed Express: Hold Rating With Cautious Outlook Amidst Management Changes and Competitive Challenges
PetMed Express Analyst Ratings
Analysts Offer Insights on Healthcare Companies: OptimizeRx (OPRX), MiMedx Group (MDXG) and Petmed Express (PETS)
Analysts Are Bullish on These Healthcare Stocks: TELA Bio (TELA), Petmed Express (PETS)
Analysts Offer Insights on Healthcare Companies: Petmed Express (PETS), Dynatronics (DYNT) and Silk Road Medical (SILK)
PetMed Express Analyst Ratings
Morgan Stanley Trims Price Target on PetMed Express to $6.50 From $7, Keeps Underweight Rating
Petmed Express (PETS) Gets a Buy From Lake Street
PetMed Express Analyst Ratings
Morgan Stanley Cuts Price Target on PetMed Express to $7 From $10 After Fiscal Q2 Miss, Keeps Underweight Rating
PetMed Express Analyst Ratings
Morgan Stanley Reiterates Underweight on PetMed Express, Maintains $17 Price Target
PetMed Express Analyst Ratings
Lake Street Initiates Coverage On PetMed Express With Buy Rating, Announces Price Target of $20
Analysts Have Conflicting Sentiments on These Consumer Goods Companies: Petmed Express (PETS) and Petco Health and Wellness Company (WOOF)
Morgan Stanley Adjusts Price Target on PetMed Express to $17 From $18, Maintains Underweight Rating